Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Jenkins Suggests "Complete Response" Letter Transparency Could Prompt Better Drug Applications, Faster Reviews

Dec 07 2009

• By The Pink Sheet

Related Content

FDA Draws Upon New Authority To Mandate Elements OF ESA Labeling

Aug 04 2008

FDA Ponders Whether To Publicly Discuss Pending NDAs And INDs; Should Agency Reply To Studies Published In Journals?

Nov 30 2009

FDA Is Expanding Transparency Efforts To Focus On Industry Questions

Nov 13 2009

The Good Old Days: FDA's Jenkins Instructs Reviewers To Meet Original User Fee Review Time Standard

Dec 07 2009

REMS Assessments Need Very Recent Data, FDA Draft Guidance Says

Oct 05 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window